Your browser doesn't support javascript.
loading
Outcomes of Bariatric Surgery in Patients with Schizophrenia.
Miñambres, Inka; Rubio-Herrera, Miguel Ángel; Nicolau, Joana; Milad, Camila; Morales, Maria José; Bueno, Marta; Calañas, Alfonso; Carceller-Sindreu, Mar; de Hollanda, Ana.
Afiliação
  • Miñambres I; Servicio de Endocrinología, Hospital de La Santa Creu i Sant Pau, 08041 Barcelona, Spain.
  • Rubio-Herrera MÁ; CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), 28029 Madrid, Spain.
  • Nicolau J; Departament de Medicina, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain.
  • Milad C; Servicio de Endocrinología y Nutrición, Hospital Clínico San Carlos, 28040 Madrid, Spain.
  • Morales MJ; Departamento de Medicina, Universidad Complutense, 28040 Madrid, Spain.
  • Bueno M; Servicio de Endocrinología, Hospital de Son Llàtzer, 07198 Mallorca, Spain.
  • Calañas A; Servicio de Endocrinología, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
  • Carceller-Sindreu M; Servicio de Endocrinología, Complexo Hospitalario Universitario de Vigo, 36312 Pontevedra, Spain.
  • de Hollanda A; Servicio de Endocrinología y Nutrición, Hospital Universitari Arnau de Vilanova, 25198 Lleida, Spain.
Nutrients ; 16(15)2024 Jul 31.
Article em En | MEDLINE | ID: mdl-39125367
ABSTRACT

BACKGROUND:

Outcomes of bariatric surgery (BS) in patients with schizophrenia are poorly understood. We aimed to analyze the effects of BS in patients with schizophrenia (SZ) or schizoaffective disorder (SZA).

METHODS:

This was a multicenter, retrospective case-control study in patients with SZ or SZA who had undergone BS in seven public referral hospitals in Spain. Controls without psychiatric comorbidity were selected in a 14 ratio. Detailed clinical and biochemical data were collected preoperatively and at 12, 24, 36, 48, and 60 months after BS.

RESULTS:

Twenty patients with SZ (n = 15; 75%) or SZA (n = 5; 25%) and 80 matched controls were studied. There were no differences between patients and controls concerning the evolution of the percentage of total weight loss. The remission rate of the main comorbidities was similar between groups except for hypertension, which was lower in patients with a psychotic disorder from year 3. There were no mortalities within 30 days of surgery in either group. The psychiatric medication burden did not change during follow-up.

CONCLUSIONS:

BS is safe and effective in carefully selected patients with SZ. The course of the psychiatric disease does not seem to be worsened by the procedure.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Redução de Peso / Cirurgia Bariátrica Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Nutrients Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Redução de Peso / Cirurgia Bariátrica Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Nutrients Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha